Posters
Repeatability and agreement of objective refraction and high order aberrations
Poster Details
First Author: G.Auffarth GERMANY
Co Author(s): J. Usinger I. Baur J. Weindler P. Poompokawat R. Khoramnia
Abstract Details
Purpose:
The purpose is to compare the objective refraction, provided from the Pentacam AXL Wave (P_AXL_W) (OCULUS Optikgeräte GmbH) and the ARK 1s (Nidek) and the ORK (Schwind) for phakic, pseudophakic and keratoconus eyes
Setting:
International Vision Correction Research Centre (IVCRC), Dept. of Ophthalmology, University Eye Clinic Heidelberg
Methods:
Prospective, randomized study with three consecutive measurements per eye with all three devices. Only measurements with a good quality of the respective parameter were included as provided by the device. Agreement was assessed with Mean +/- SD and Bland Altman, Repeatability was assessed with Coefficient of variation (CV)
Results:
Phakic eyes: P_AXL_W: n=34, mean abs. SEQ=0,99D, SD=0,08D, mean abs. CV=0,638; ARK 1s : n=34, mean abs. SEQ=1,07D, SD=0,08D, mean abs. CV=0,003; ORK: n=29, mean abs. SEQ=1,5D, SD=0,3D, mean abs. CV=3,29.
Pseudophakic eyes: P_AXL_W: n=20, mean abs. SEQ=0,22D, SD=0,08D, mean abs. CV=0,552; ARK 1s : n=20, mean abs. SEQ=0,26D, SD=0,09D, mean abs. CV=0,71; ORK: n=16, mean abs. SEQ=1,3D, SD=0,26D, mean abs. CV=0,202.
Keratoconic eyes: P_AXL_W: n=21, mean abs. SEQ=1,9D, SD=0,15D, mean abs. CV=0,25; ARK 1s : n=21, mean abs. SEQ=2,39D, SD=0,1D, mean abs. CV=0,534; ORK: n=20, mean abs. SEQ=2,2D, SD=0,34D, mean abs. CV=0,25
Conclusions:
The numbers of eyes are same for the ARK 1s and the P_AXL_W but for the ORK less eyes were available due to the lower success rate. The comparison of the SEQ provided by P_AXL_W and the ARK 1s showed no statistical differences for phakic and pseudophakic eyes. The ORK provides significant differences. For the keratoconic eyes, the P_AXL_W and the ARK 1s showed similar small repeatability. The comparison of the SEQ provided by the ORK and the P_AXL_W showed no statistical difference.
Financial Disclosure:
receives consulting fees, retainer, or contract payments from a competing company, travel has been funded, fully or partially, by a competing company